Clinical Trials Directory

Trials / Completed

CompletedNCT05525195

Influence of Preop Fibrinogen on Blood in Pediatric Cardiac Surgery

Influence of Preoperative Fibrinogen Levels on Blood Loss and Transfusions in Pediatric Cardiac Surgery

Status
Completed
Phase
Study type
Observational
Enrollment
932 (actual)
Sponsor
Brugmann University Hospital · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

Fibrinogen plays an important role in the coagulation cascade. Low levels of preoperative fibrinogen have been associated in adults with higher blood and transfusion requirements during surgery. Guidelines from the European Society of Anesthesiology and Intensive Care recommends fibrinogen substitution based on viscoelastic tests in adult cardiac surgery. Cardiopulmonary bypass results in a profound hemodilution and dilution of all coagulation factors. This is especially true in children where the priming volume of the cardiopulmonary bypass circuit is much higher compared to the patient's weight than in adults. Cardiopulmonary bypass generates high levels of tissue plasminogen activator resulting in a hyperfibrinolysis, further lowering fibrinogen levels. The aim of this retrospective study is to explore a possible relationship between preoperative fibrinogen levels and perioperative blood loss, as well as transfusion requirements in children undergoing cardiac surgery.

Conditions

Interventions

TypeNameDescription
PROCEDURECongenital cardiac surgeryAll children who underwent congenital cardiac surgery with cardiopulmonary bypass between 2008 and 2018

Timeline

Start date
2022-09-17
Primary completion
2023-01-25
Completion
2023-02-10
First posted
2022-09-01
Last updated
2023-07-27

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05525195. Inclusion in this directory is not an endorsement.